Hemolytic uremic syndrome in a developing country: consensus guidelines

A Bagga, P Khandelwal, K Mishra, R Thergaonkar… - Pediatric …, 2019 - Springer
Background Hemolytic uremic syndrome (HUS) is a leading cause of acute kidney injury in
children. Although international guidelines emphasize comprehensive evaluation and …

Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?

F Bridoux, E Desport, V Frémeaux-Bacchi… - Clinical Journal of the …, 2011 - journals.lww.com
Results All patients presented with hematuria, associated with chronic renal failure and
proteinuria in five patients, three of whom had nephrotic syndrome. Five patients had …

Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome

F Fakhouri, M Jablonski, J Lepercq… - Blood, The Journal …, 2008 - ashpublications.org
The HELLP syndrome, defined by the existence of h emolysis, e levated l iver enzymes, and
l ow p latelet count, is a serious complication of pregnancy-related hypertensive disorders …

Regulators of complement activity mediate inhibitory mechanisms through a common C3b‐binding mode

F Forneris, J Wu, X Xue, D Ricklin, Z Lin… - The EMBO …, 2016 - embopress.org
Regulators of complement activation (RCA) inhibit complement‐induced immune responses
on healthy host tissues. We present crystal structures of human RCA (MCP, DAF, and CR 1) …

Atypical haemolytic uraemic syndrome

D Kavanagh, THJ Goodship… - British medical bulletin, 2006 - academic.oup.com
The haemolytic uraemic syndrome (HUS) is characterized by the triad of thrombocytopenia,
microangiopathic haemolytic anaemia and acute renal failure. HUS may be classified as …

[PDF][PDF] Actualización en síndrome hemolítico urémico atípico: diagnóstico y tratamiento. Documento de consenso

JM Campistol, M Arias, G Ariceta, M Blasco… - Nefrología …, 2015 - SciELO Espana
El síndrome hemolítico urémico (SHU) es una entidad clínica definida por la tríada anemia
hemolítica no inmune, trombocitopenia e insuficiencia renal aguda, en la que las lesiones …

[HTML][HTML] Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy

H Izzedine, M Mangier, V Ory, SY Zhang, K Sendeyo… - Kidney international, 2014 - Elsevier
Renal toxicity constitutes a dose-limiting side effect of anticancer therapies targeting
vascular endothelial growth factor (VEGF). In order to study this further, we followed up 29 …

Hemolytic uremic syndrome recurrence after renal transplantation

C Loirat, V Fremeaux‐Bacchi - Pediatric transplantation, 2008 - Wiley Online Library
About 60% of non‐Stx‐associated aHUS are due to the defect of protection of endothelial
cells from complement activation, secondary to mutations in the genes of CFH, MCP, IF, BF …

Crosstalk between platelets and the complement system in immune protection and disease

A Verschoor, HF Langer - Thrombosis and haemostasis, 2013 - thieme-connect.com
Platelets have a central function in repairing vascular damage and stopping acute blood
loss. They are equally central to thrombus formation in cardiovascular diseases such as …

Advances in understanding of pathogenesis of aHUS and HELLP

CJ Fang, A Richards, MK Liszewski… - British journal of …, 2008 - Wiley Online Library
Both atypical haemolytic uraemic syndrome (aHUS) and the HELLP syndrome (haemolytic
anaemia, elevated liver enzymes, and low platelets) are thrombotic microangiopathies …